Please login to read the full article.
Scrip Regulatory Affairs
Device, drug makers ask US FDA to clarify off-label policy
04 August 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA consults on "scientific exchange" on off-label uses of drugs, devices
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- US FDA clarifies which device modifications will need a new 510(k) submission
- US FDA SOP seeks to convey new regulatory expectations to medtech firms faster
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
